Strategic Partnership Recent Life Science Group partnership signals potential co-selling or distribution opportunities. Leverage this alliance to access a broader product catalog and accelerate market reach for US Biologicals offerings.

Broad Customer Base Customer portfolio includes leading pharmaceutical and biotechnology firms domestically and internationally, indicating high demand for biochemicals, antibodies, recombinant proteins and culture media. Target tier-one accounts for expanded quantities and custom kits.

Growth Scale Revenue range of 10M to 25M with mid-market footprint suggests room to upsell larger bulk orders, process development materials, and temperature-controlled or specialized media tailored for manufacturing and R&D labs.

Product Depth Diverse product lineup across biochemicals, antibodies, recombinant proteins, and molecular biology kits offers cross-sell potential to labs upgrading workflows, adopting new genomic tools, or expanding assay portfolios.

Digital Readiness Existing tech stack includes e-commerce functionality, analytics tools, and modern web infrastructure, enabling targeted digital outreach, accurate product recommendations, and streamlined procurement for potential customers.